Significant correlation between serum biomarkers and outcome in neonatal hypoxic-ischaemic encephalopathy.
Journal
Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968
Informations de publication
Date de publication:
31 Jul 2024
31 Jul 2024
Historique:
revised:
27
06
2024
received:
28
11
2023
accepted:
19
07
2024
medline:
1
8
2024
pubmed:
1
8
2024
entrez:
1
8
2024
Statut:
aheadofprint
Résumé
Associations between serum biomarkers S100 calcium-binding protein B (S100B) and neuron-specific enolase (NSE) in neonates with hypoxic-ischaemic encephalopathy (HIE) offer contradicting data in regard to neurocognitive outcome. The aim of our study was to provide another dataset to answer this question if S100B or NSE correlates to outcome in neonatal HIE. In addition, we investigate whether amplitude-integrated EEG (aEEG) or magnetic resonance imaging (MRI) also has predictive value. In neonates with HIE born in Vorarlberg, Austria, (n = 34) from 2012to 2020, NSE and S100B serum levels were measured on day one. aEEG was installed at admission and MRI performed within 7 days. Surviving children (n = 27) were categorised as good or poor outcome by using an age-appropriate neurocognitive test and a standardised neurological follow-up. Positive and negative predictive values and receiver operating characteristic curves were calculated to evaluate the prognostic value. S100B showed best positive and negative predictive value, 72.7% and 90.5%, respectively, and a significant area under the curve of 0.820. NSE showed a positive and a negative predictive value of 43.8% and 81.3% and an area under the curve of 0.757. Severely abnormal aEEG and abnormal MRI significantly correlated with outcome (p = 0.024 and 0.001 respectively). S100B and NSE on day one, severely abnormal aEEG and abnormal MRI show a significant correlation and good predictive value for neurocognitive outcome.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.
Références
Ahearne CE, Boylan GB, Murray DM. Short and long term prognosis in perinatal asphyxia: an update. World J Clin Pediatr. 2016;5(1):67‐74.
Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005;365(9460):663‐670.
Laptook AR, Shankaran S, Tyson JE, et al. Effect of therapeutic hypothermia initiated after 6 hours of age on death or disability among newborns with hypoxic‐ischemic encephalopathy: a randomised clinical trial. JAMA. 2017;318(16):1550‐1560.
Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole‐body hypothermia for neonates with hypoxic‐ischemic encephalopathy. N Engl J Med. 2005;353(15):1574‐1584.
Azzopardi DV, Strohm B, Edwards AD, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009;361(14):1349‐1358.
Skranes JH, Lohaugen G, Schumacher EM, et al. Amplitude‐integrated electroencephalography improves the identification of infants with encephalopathy for therapeutic hypothermia and predicts neurodevelopmental outcomes at 2 years of age. J Pediatr. 2017;187:34‐42.
Han Y, Fu N, Chen W, et al. Prognostic value of electroencephalography in hypothermia‐treated neonates with hypoxic‐ischemic encephalopathy: a meta‐analysis. Pediatr Neurol. 2019;93:3‐10.
Steiner M, Urlesberger B, Giordano V, et al. Outcome prediction in neonatal hypoxic‐ischaemic encephalopathy using neurophysiology and neuroimaging. Neonatology. 2022;119(4):483‐493.
Massaro AN, Chang T, Kadom N, et al. Biomarkers of brain injury in neonatal encephalopathy treated with hypothermia. J Pediatr. 2012;161(3):434‐440.
Massaro AN, Chang T, Baumgart S, McCarter R, Nelson KB, Glass P. Biomarkers S100B and neuron‐specific enolase predict outcome in hypothermia‐treated encephalopathic newborns. Pediatr Crit Care Med. 2014;15(7):615‐622.
Lv H, Wang Q, Wu S, et al. Neonatal hypoxic ischemic encephalopathy‐related biomarkers in serum and cerebrospinal fluid. Clin Chim Acta. 2015;450:282‐297.
Murray DM. Biomarkers in neonatal hypoxic‐ischemic encephalopathy‐review of the literature to date and future directions for research. Handb Clin Neurol. 2019;162:281‐293.
Echeverria‐Palacio CM, Agut T, Arnaez J, Valls A, Reyne M, Garcia‐Alix A. Neuron‐specific enolase in cerebrospinal fluid predicts brain injury after sudden unexpected postnatal collapse. Pediatr Neurol. 2019;101:71‐77.
Nagdyman N, Grimmer I, Scholz T, Muller C, Obladen M. Predictive value of brain‐specific proteins in serum for neurodevelopmental outcome after birth asphyxia. Pediatr Res. 2003;54(2):270‐275.
Celtik C, Acunas B, Oner N, Pala O. Neuron‐specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy. Brain Dev. 2004;26(6):398‐402.
Catherine RC, Bhat BV, Adhisivam B, Bharadwaj SK, Vinayagam V, Chinnakali P. Neuronal biomarkers in predicting neurodevelopmental outcome in term babies with perinatal asphyxia. Indian J Pediatr. 2020;87(10):787‐792.
Li M, Ye M, Zhang G. Aberrant expression of miR‐199a in newborns with hypoxic‐ischemic encephalopathy and its diagnostic and prognostic significance when combined with S100B and NSE. Acta Neurol Belg. 2021;121(3):707‐714.
Jacobs SE, Berg M, Hunt R, Tarnow‐Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev. 2013;2013(1):CD003311.
Bayley N. Bayley II: Bayley Scales of Infant Development – Deutsche Version. 2nd ed. Pearson Assessment and Information; 2008.
Bayley N. Bayley III: Bayley Scales of Infant and Toddler Development‐ Deutsche Version. 3rd ed. Pearson Assessment; 2014.
Moore T, Johnson S, Haider S, Hennessy E, Marlow N. Relationship between test scores using the second and third editions of the Bayley scales in extremely preterm children. J Pediatr. 2012;160(4):553‐558.
Wechsler D. WPPSI‐IV: Wechsler Preschool and Primary Scale of Intelligence – Deutsche Fassung. 4th ed. Pearson Assessment; 2018.
Wechsler D. WISC‐V: Wechsler Intelligence Scale for Children – Deutsche Fassung. 5th ed. Pearson Assessment; 2017.
Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39(4):214‐223.
Fiser DH. Assessing the outcome of pediatric intensive care. J Pediatr. 1992;121(1):68‐74.
Shankaran S, Barnes PD, Hintz SR, et al. Brain injury following trial of hypothermia for neonatal hypoxic‐ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2012;97(6):F398‐F404.
Michniewicz B, Szpecht D, Sowinska A, Sibiak R, Szymankiewicz M, Gadzinowski J. Biomarkers in newborns with hypoxic‐ischemic encephalopathy treated with therapeutic hypothermia. Childs Nerv Syst. 2020;36(12):2981‐2988.
Luo Q, Pin T, Dai L, et al. The role of S100B protein at 24 hours of postnatal age as early indicator of brain damage and prognostic parameter of perinatal asphyxia. Global Pediatric Health. 2019;6:1‐7.
Kang O‐H, Jahn P, Eichhorn J, Müller A, Sabir H. Korrelation zwischen verschiedenen MRT Scores und motorische Langzeitoutcome bei gekühlten asphyktischen Neugeborenen. Z Gebutshilfe Neonatol. 2023;227(3):19‐20.
Grossmann KR, Westblad ME, Blennow M, Lindström K. Outcome at early school age and adolescence after hypothermia‐treated hypoxic‐ischaemic encephalopathy: an observational, population‐based study. Arch Dis Child Fetal Neonatal Ed. 2023;108:295‐301.